Recent developments in immunization against diarrheal diseases.
D000284:Administration, Oral; D000937:Antigen-Antibody Reactions; D000992:Antitoxins / Q000627:therapeutic use; D022121:Cholera Vaccines / Q000008:administration & dosage; D003016:Clostridium perfringens / Q000472:pathogenicity; D003967:Diarrhea / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D004768:Enterotoxins / Q000378:metabolism; D004926:Escherichia coli / Q000472:pathogenicity; D006801:Humans; D007114:Immunization / Q000379:methods*; D012475:Salmonella / Q000472:pathogenicity; D012703:Serotyping; D012764:Shigella sonnei / Q000472:pathogenicity; D014121:Toxoids / Q000008:administration & dosage; D014435:Typhoid Fever / Q000276:immunology; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014734:Vibrio cholerae / Q000472:pathogenicity
D000992:Antitoxins; D022121:Cholera Vaccines; D004768:Enterotoxins; D014121:Toxoids; D014436:Typhoid-Paratyphoid Vaccines; D014613:Vaccines, Attenuated